Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Exiqon Appoints President and General Manager of new US Operations

Published: Friday, January 06, 2006
Last Updated: Friday, January 06, 2006
Bookmark and Share
Michael Kallelis will have the overall responsibility for launching and operating Exiqon’s US office to be located in the Boston area.

Exiqon A/S has announced the appointment of Michael Kallelis as President and General Manager of Exiqon’s new US operations.

Mr. Kallelis will have the overall responsibility for launching and operating Exiqon’s US office to be located in the Boston area.

A key focus of the new facility will be to expand the sales force to support Exiqon’s miRCURY™ microRNA detection products.

Before joining Exiqon, Mr. Kallelis served as a Vice President at Archemix Corp and prior to that as the Executive Vice President and General Manager of Avecia Biotechnology.

He also served as Chief Operating Officer and co-founder of Boston BioSystems, a leading GMP manufacturer of oligonucleotides, which was acquired by Avecia in 1999.

Over his career, Mr. Kallelis has acquired significant expertise in rapidly building up new businesses from start-up to commercially viable enterprises and has taken a lead management role in mergers and acquisitions.

"Mike possesses the commercial and operational leadership skills which will secure a strong launch of Exiqon’s US operations," said Lars Kongsbak, President and CEO of Exiqon.

"Mike also has extensive experience managing technical life science companies and brings the perfect blend of sales, marketing and operations roles that make him a good match for Exiqon’s growing business."

"During 2005, Exiqon has continued to grow its product sales, quarter to quarter, and a full presence in the US market is an obvious next step," said Jack Johansen, Chairman of the Board of Exiqon. "We are very pleased to have Mike lead this important operation."

Exiqon’s new offices will be located in the Boston area to take full advantage of the life science labor pool and large biotech presence.

The new US office plans to begin recruiting its sales staff and administrative support roles immediately. The site will be operational in the first quarter of this year.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Exiqon Secures Funding to Accelerate Growth
Exiqon A/S has announced the issue of a senior secured note in the amount of DKK 40 million (‘Note’).
Thursday, November 12, 2015
Exiqon Licenses Biomarkers From Aarhus University Hospital
Exiqon A/S has exclusively licensed prostate cancer biomarkers discovered and validated by Aarhus University Hospital, Department of Molecular Medicine (MOMA).
Wednesday, December 03, 2014
Redefining High Risk Patients With Stage II Colon Cancer
microRNA-21 identified as an independent prognostic biomarker.
Friday, September 12, 2014
Exiqon Licenses Locked Nucleic Acids for Infectious Disease Diagnostics to BD
BD will use Exiqon's proprietary LNA™ technology in defined products for infectious disease diagnostics.
Wednesday, June 23, 2010
Exiqon and MultiD Sign Development and Distribution Agreement for microRNA qPCR Analysis Solution
Agreement incorporates a specifically adapted version of the GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform.
Wednesday, May 26, 2010
Exiqon Wins Ernst & Young Entrepeneur of the Year Award
Exiqon selected as winner in the BIOTECH 2005 category.
Tuesday, November 22, 2005
Exiqon A/S appoints permanent CEO

Monday, February 24, 2003
Scientific News
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!